Received: 1 October 2020
Accepted: 17 June 2021
First Online: 30 June 2021
: The present study has been approved by the ethics committee of CERBA/LABIOGENE and the National Ethics Committee for Health Research of Burkina Faso.CERS20186065, 6 June 2018, retrospectively registered. Free and written consent was obtained from all participants of this study. The anonymity and confidentiality of the patients were respected as stated in the IRB (Institutional Review Board) protocol.
: Not applicable.
: The authors declare that they have no competing interests.